The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine

Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…